Access to Information Requests Completed - May 2015

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of May 2015
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2014-00913 Adverse Reaction Report (AER) for Taxotere (docetaxel). Report number: E2B_00054746. Disclosed in part 12
A-2014-00916 Adverse Reaction Report (AER) for Flagyl (metronidazole). Report number: 000583254. Disclosed in part 3
A-2014-00932 Adverse Reaction Report (AER) for Arava (leflunomide). Report number: 000551925. Disclosed in part 11
A-2014-00988 Adverse Reaction Report (AER) for report number: 000579651. Disclosed in part 3
A-2014-01029 Data on the most recent year available on all Occurrence Reports and Critical Incident Reports from the First Nations and Inuit Health Branch Occurrence Reporting System. Disclosed in part 455
A-2014-01206 Information regarding Nattokinase (capsule), Natural Product Number (NPN) 138394 by Flora Manufacturing & Distributing Inc. Disclosed in part 643
A-2014-01266 Information on Lexier Medical Management Services regarding sales of class IV medical devices (Synvisc Hyan G-G20 and Synvisc-One) in Canada, especially information related to the  letter dated Nov. 19, 2014, signed by Vini Khurana All exempted 0
A-2014-01303 Adverse Reaction Report (AER) for Kaletra. Report numbers: E2B_00150794 and E2B_00122029. Disclosed in part 35
A-2014-01375 Information regarding the number of clients registered with licensed producers under the Marihuana for Medical Purposes Regulations (MMPR) (Oct. 31, 2014 to Dec. 31, 2014) Disclosed in part 1
A-2014-01378 All documents in the Ministerial Executive Correspondence System (MECS) for the following file: 14-101196-922 – Shared Travel Service Initiative All disclosed 20
A-2014-01383 Documents between the minister of Health and provincial and territorial health ministers that relate to prescription drug coverage, and as a result of the autumn 2014 meeting in Banff, Alberta (Jan. 1, 2014 to Feb. 16, 2015) Disclosed in part 47
A-2014-01387 Copy of the approval or rejection letter sent to the Marihuana for Medical Purposes Regulations applicant CEN-Biotech Inc. Disclosed in part 2
A-2014-01394 Information regarding the Marihuana for Medical Purposes Regulations application status for CEN Biotech Inc. Disclosed in part 2
A-2014-01402 Copy of the Ministerial Executive Correspondence System (MECS) for the following file:
14-111194-315 -  The Public Service Pay Centre in Miramichi
Disclosed in part 25
A-2014-01424 List of briefing notes and memoranda created and sent to the Health Canada minister and deputy minister (Jan 1, 2015 to Feb 20, 2015) Disclosed in part 46
A-2014-01425 Documentation exchanged between the Health Canada minister and Government of Quebec ministers (Nov 1, 2014 to Feb 24, 2015) All disclosed 8
A-2014-01453 All documents regarding the Adverse Reaction Reports for Cyclobenzaprine and Diclo-miso 75MG-200 MCG (Diclofenac/Misoprostol). (Oct. 10, 2014 to Nov. 5, 2014). No records exist 0
A-2014-01483 Correspondence between the minister of Health Canada, including the Deputy Minister, and the Quebec ministers of health and public safety regarding medical marijuana or pot (Nov 1, 2014 to March 13, 2015) All disclosed 4
A-2014-01529 All correspondence related to the development of an Ebola vaccine and the licensing of a vaccine to BioProtection Systems, a subsidiary of NewLink Genetics. (Jan. 1, 2009 to Dec. 31, 2010) No records exist 0
A-2014-01534 Adverse Reaction Report (AER) for Eloxatin (oxaliplatin). Report number: 000618907. Disclosed in part 5
A-2014-01547 Information related to the total number of residential, licensed medical marijuana grow operations, applications for commercial licensed producers received under the Marihuana for Medical Purposes Regulations for the following jurisdictions: British Columbia, Kamloops, Kelowna, Vernon, Lumby, Enderby, Lake. (Mar. 31, 2014) Disclosed in part 2
A-2014-01568 Documents related to Health Canada’s Regulatory Transparency and Openness Framework Action Plan for April 2015-March 2016, including draft and interim versions, and its plans to support and schedule rollout of activities All excluded 0
A-2015-00018 Documentation regarding notification of health impairment and/or health effect in the possession of the institution or its designees, submitted by the equipment owner, Northland Power Inc. and/or its related entities and by the equipment manufacturer, General Electric and/or its related entities for the McLean’s Mountain Wind L.P. Wind Turbine Project in the Township of Northeastern Manitoulin and Islands (Nemi) on Manitoulin Island, Ontario (May, 2013 to March 31, 2015) No records exist 0
A-2015-00029 All communications to and from the Office of the Parliamentary Secretary to the Minister of Health pertaining to letterheads, business cards, door plaques and other identifying materials including related invoices (September to November 2013) No records exist 0
A-2015-00031 All call-ups and contracts processed by this institution in the Western Region, specifically the city of Calgary, the Pacific Region, specifically for Vancouver, Burnaby, Delta, Langley, Richmond, Abbotsford and Surrey, the Greater Toronto Area and the National Capital Region under the terms of the Standing Offer or Supply Arrangement for Temporary Help Services during the period of October, November and December 2014. All disclosed 9
A-2015-00032 Documentation which indicates all casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during October, November and December 2014. All disclosed 1
A-2015-00033 Documentation which indicates all appointments term by this institution in the National Capital Region under the term of the Public Service Employment Act during October, November and December 2014. All disclosed 1
A-2015-00049 Information regarding the number of patient registered, total grams produced, total grams sold, total grams stored and the monthly revenue for the following licensed producers under the Marihuana for Medical Purposes Regulations: Bedrocan Canada Inc., Canna Farms Ltd, CanniMed Ltd, Delta 9 Bio-Tech Inc., In-The-Zone Produce Ltd, Mettrum Ltd, MedReleaf Corp., OrganiGram Inc., The Peace Naturals Project Inc., ThunderBird Biomedical Inc., Tilray Tweed Inc., Whistler Medical Marijuana Corp. (Oct. 1,     2013 to Sep. 1, 2014) Disclosed in part 815
A-2015-00060 Information related to the number of authorizations under the Health Canada’s Special Access Programme (SAP) for preservative free Timolol, also known as Timolol PF or Timoptic in Ocudose, by year for 2012, 2013 and 2014 All disclosed 1
A-2015-00066 Adverse Reaction Report (AER) for Vaxigrip vaccine. Report number: 000631224. Disclosed in part 1
A-2015-00074 Adverse Reaction Report (AER) for the following product/report numbers: Methadone (000629302; 000627918; 000628142; 000629047; 000630188; 000631199; 000632925; 000634453; 000636886 and 000630076) Disclosed in part 12
A-2015-00076 Copy of the final rejection letter that was sent to CEN Biotech Inc. for their application to the Marihuana Medical Purposes Regulations (MMPR) program Disclosed in part 2
A-2015-00087 Adverse Reaction Report (AER) for NORVIR. Report number: 000631156. Disclosed in part 1
A-2015-00089 Adverse Reaction Report (AER) for LUPRON. Report number: 000630201. Disclosed in part 1
A-2015-00090 Documentation from Health Canada and the Department of National Health and Welfare relating to child abuse or criminal charges arising out of abuse at Bishop Horden Indian Residential School from 1950 to 1970 No records exist 0
A-2015-00111 All communique and reports regarding virtual reality therapy, especially for posttraumatic stress disorder (PTSD) (Jan. 1, 2010 to May 4, 2015) No records exist 0
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: